SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-23-000057
Filing Date
2023-09-07
Accepted
2023-09-07 08:00:57
Documents
14
Period of Report
2023-09-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K angn-20230907.htm   iXBRL 8-K 23629
2 EX-99.1 ex991-2023x09x07xxeltxxx3m.htm EX-99.1 17947
6 imagea.jpg GRAPHIC 17121
  Complete submission text file 0001601485-23-000057.txt   202297

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20230907.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20230907_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20230907_pre.xml EX-101.PRE 13130
8 EXTRACTED XBRL INSTANCE DOCUMENT angn-20230907_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 231241004
SIC: 2834 Pharmaceutical Preparations